Curcumin: A natural antiinflammatory agent

Indian Journal of Pharmacology

Volumn 37, Issue 3, 2005, Pages 141-147

  Kohli, K ^a   Ali, J ^a   Ansari, M J ^a   Raheman, Z ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Cyclo oxygenase (COX); Free radical scavenger; Inflammation

Indexed keywords

ANTIINFLAMMATORY AGENT; BIS (4 HYDROXY CINNAMOYL)METHANE; CURCUMIN; CYTOKINE; DRUG ANALOG; FERULOYL 4 HYDROXY CINNAMOYL METHANE; FREUND ADJUVANT; HYDROCORTISONE ACETATE; MONOCYTE CHEMOTACTIC PROTEIN 1; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE; SCAVENGER; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; CURCUMA LONGA; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG STRUCTURE; ENZYME INHIBITION; ENZYME STABILITY; IC 50; MEDICINAL PLANT; NONHUMAN; PAW EDEMA; PROSTAGLANDIN SYNTHESIS INHIBITION; REVIEW; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

EID: 21244491978     PISSN: 02537613     EISSN: None     Source Type: Journal    
DOI: 10.4103/0253-7613.16209     Document Type: Review

References (90)

1. Nadkarni AK. Indian Materia Medica. Bombay: Popular Prakashan PVP; 1954.
2. Leung A. Encyclopedia of common natural ingredients used in food, drugs & cosmetics. John Weily 198;31: 314.
3. Chandra D, Gupta S. Anti-inflammatory and anti-arthritic activity of volatile oil of Curcuma longa (Haldi). Indian J Med Res 1972;60:138-42.
4. Cooper TH, Clark G, Guzinski J. In: Chi-Tang Ho, editor. Am Chem Soc Washington, DC, 1994; 23: 231-6.
5. Arora R, Basu N, Kapoor V. Anti-inflammatory studies on Curcuma longa (turmeric). Indian J Med Res 1971;59:1289-95.
6. Negi PS, Jayaprakasha GK, Jagan Mohan Rao L, Sakariah KK. Antibacterial activity of turmeric oil: a byproduct from curcumin manufacture. J Agric Food Chem 1999;47:4297-300.
7. Bourne KZ, Bourne N, Reising SF, Stanberry LR. Plant products as topical microbicide candidates: assessment of in vitro and in vivo activity against herpes simplex virus type 2. Antiviral Res 1999;42:219-26.
8. Apisariyakul A, Vanittanakom N, Buddhasukh D. Antifungal activity of turmeric oil extracted from Curcuma longa (Zingiberaceae). J Ethnopharmacol 1995;49:163-9.
9. Kawamori T, Lubet R, Steele VE. Chemopreventative effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer. Cancer Res 1999;59:597-601.
10. Itthipanichpong C, Ruangrungsi N, Kemsri W, Sawasdipanich A. Antispasmodic effects of curcuminoids on isolated guinea-pig ileum and rat uterus. J Med Assoc Thai 2003;86:299-309.
11. Park E J, Jeon CH, Ko G. Protective effect of curcumin in rat liver injury induced by carbon tetrachloride. J Pharm Pharmacol 2000;52:437-40.
12. Mazumder A, Wang S, Neamati N, Nicklaus M, Sunder S, Chen J, et al. Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1integrase and protease. J Med Chem 1996;39:2472-81.
13. Sui Z, Salto R, Li J, Craik C, Ortiz de Montellano PR. Inhibition of the HIV-1 and HIV-2 proteases by curcumin and curcumin boron complexes. Bioorg Med Chem 1993;1:415-22.
14. James JS. AIDS Treatment News; 1993;176:1-3.
15. Srimal RC, Khanna NM, Dhawan BN. A preliminary report on anti inflammatory activity of curcumin. Int J Pharm 1971;3:10.
16. Srimal RC, Dhawan BN. Pharamacology of diferuloyl methane, a non steroidal anti-inflammatory drug. J Pharm Pharmacol 1973;25:447.
17. Mukhopadhyay A, Basu N, Ghatak N. Anti-inflammatory and irritant activities of curcumin analogues in rats. Agents Actions 1982;12:508-15.
18. Srinivasan KR. A chromatographic study of the curcuminoids in curcuma longa Linn. J Pharm Pharmacol 1953;5:448-53.
19. Rao TS, Basu N, Siddiqui HH. Anti-inflammatory activity of curcumin analogues. Indian J Med Res 1982;75:574-8.
20. Ghatak N, Basu N. Sodium curcuminate as an effective anti-inflammatory agent. Indian J Exp Biol 1972;10:235-6.
21. Mukhopadhyay A, Basu N, Ghatak N, Gujral PK. Structure activity relationship with respect to anti-inflammatory activity in a series of curcumin analogues. Proc Int Union Physiol Sci 1974;10:241-5.
22. Deodhar SD, Sethi R, Srimal RC. Preliminary study on antirheumatic activity of curcumin (Diferuloyl methane). Indian J Med Res 1980;71:632-43.
23. Satoskar RR, Shah SJ, Shenoy SG. Evaluation of anti-inflammatory property of curcumin in patients with post operative inflammation. Int J Clin Pharmacol Ther Toxicol 1986;24:651-4.
24. Kuttan R, Sudheeran PC, Joseph CD. Turmeric and curcumin as topical agents in cancer therapy. Tumori 1987;73:29-31.
25. Lal B, Kapoor AK, Asthana OP, Agrawal PK, Prasad R, Kumar P, et al. Efficacy of curcumin in the management of chronic anterior uveitis. Phytother Res 1999;13:318-22.
26. Lal B, Kapoor AK, Agrawal PK, Asthana OP, Srimal RC. Role of curcumin in idiopathic inflammatory orbital pseudotumours. Phytother Res 2000;14:443-7.
27. Srivastava KC, Bordia A, Verma SK. Curcumin, a major component of food spice turmeric ( Curcuma longa ) inhibits aggregation and alters eicosanoid metabolism in human blood platelets. Prostaglandins Leukot Essent Fatty Acids 1995;52:223-7.
28. Conney AH, Lysz T, Ferraro T, Abidi TF, Manchand PS, Laskin JD, Huang MT. Inhibitory effect of curcumin and some related dietary compounds on tumor promotion and arachidonic acid metabolism in mouse skin. Adv Enzyme Regul 1991;31:385-96.
29. Joe B, Lokesh BR. Effect of curcumin and capsaicin on arachidonic acid metabolism and lysosomal enzyme secretion by rat peritoneal macrophages. Lipids 1997;32:1173-80.
30. Ammon HP, Safayhi H, Mack T, Sabieraj J. Mechanism of anti-inflammatory actions of curcumin and bowsellic acids. J Ethnopharmacol 1993;38:113-9.
31. Srivastava R. Inhibition of neutrophil response by curcumin. Agents Actions 1989;28:298-303.
32. Ramsewak RS, DeWitt DL, Nair MG. Cytotoxicity, antioxidant and anti-inflammatory activities of curcumins I-III from Curcuma longa. Phytomedicine 2000;7:303-8.
33. Skrzypczak-Jankun E, McCabe NP, Selman SH, Jankun J. Curcumin inhibits lipoxygenase by binding to its central cavity: theoretical and X-ray evidence. Int J Mol Med 2000;6:521-6.
34. Wallace JM. Nutritional and botanical modulation of the inflammatory cascade - eicosanoids, cyclooxygenases and lipoxygenases-as an adjunct in cancer therapy. Integr Cancer Ther 2002;1:7-37.
35. Huang MT, Lysz T, Ferraro T, Abidi TF, Laskin JD, Conney AH. Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res 1991;51:813-9.
36. Flynn DL, Rafferty MF, Boctor AM. Inhibition of 5-hydroxy- eicosatetraenoic acid (5-HETE) formation in intact human neutrophils by naturally-occurring diarylheptanoids: Inhibitory activities of curcuminoids and yakuchinones. Prostaglandins Leukot Med 1986;22:357-60.
37. Lukita-Atmadja W, Ito Y, Baker GL, McCuskey RS. Effect of curcuminoids as anti-inflammatory agents on the hepatic microvascular response to endotoxin. Shock 2002;17:399-403.
38. Gukovsky I, Reyes CN, Vaquero EC, Gukovskaya AS, Pandol SJ. Curcumin ameliorates ethanol and nonethanol experimental pancreatitis. Am J Physiol Gastrointest Liver Physiol 2003;284:85-95.
39. Ukil A, Maity S, Karmakar S, Datta N, Vedasiromoni JR, Das PK. Curcumin, the major component of food flavour turmeric, reduces mucosal injury in trinitrobenzene sulphonic acid-induced colitis. Br J Pharmacol 2003;139:209-18.
40. 2+ signaling. Biochem Pharmacol 1999;58:1167-72.
41. Srivastava KC, Bordia A, Verma SK. Curcumin, a major component of food spice turmeric ( Curcuma longa ) inhibits aggregation and alters eicosanoid metabolism in human blood platelets. Prostaglandins Leukot Essent Fatty Acids 1995;52:223-7.
42. Chan MM. Inhibition of tumor necrosis factor by curcumin, a phytochemical. Biochem Pharmacol 1995;49:1551-6.
43. Kobayashi T, Hashimoto S, Horie T. Curcumin inhibition of Dermatophagoides farinea-induced interleukin-5 (IL-5) and granulocyte macrophage-colony stimulating factor (GM-CSF) production by lymphocytes from bronchial asthmatics. Biochem Pharmacol 1997;54:819-24.
44. Abe Y, Hashimoto S, Horie T. Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. Pharmacol Res 1999;39:411-7.
45. Kang BY, Chung SW. Inhibition of interleukin-12 production in lipopolysaccharide-activated macrophages by curcumin. Eur J Pharmacol 1999;384:191-5.
46. Kondo A, Koshihara Y, Togari A. Signal transduction system for interleukin-6 synthesis stimulated by lipopolysaccharide in human osteoblasts. J Interferon Cytokine Res 2001;21:943-50.
47. Ruby AJ, Kuttan G. Anti-tumour and antioxidant activity of natural curcuminoids. Cancer Lett 1995;94:79-83.
48. Selvam R, Subramanian L. The anti-oxidant activity of turmeric ( Curcuma longa ). J Ethnopharmacol 1995;47:59-67.
49. Kunchandy E, Rao MNA. Oxygen radical scavenging activity of curcumin. Int J Pharm 1990;58:237-40.
50. Zhang F, Altorki NK, Mestre JR, Subbaramaiah K, Dannenberg AJ. Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signaling complex. Carcinogenesis 1999;20:445-51.
51. Goel A, Boland CR, Chauhan DP. Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells. Cancer Lett 2001;172:111-8.
52. Kim HY, Park EJ, Joe EH, Jou I. Curcumin suppresses Janus kinase-STAT inflammatory signaling through activation of Src homology 2 domain-containing tyrosine phosphatase 2 in brain microglia. J Immuno 2003;171:6072-9.
53. Srivastava R, Srimal RC. Modification of certain inflammation-induced biochemical changes by curcumin. Indian J Med Res 1985;81:215-23.
54. Ireson C, Orr S, Jones DJ, Verschoyle R, Lim CK, Luo JL, et al.Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production. Cancer Res 2001;61:1058-64.
55. Gupta B, Ghosh B. Curcuma longa inhibits TNF-alpha induced expression of adhesion molecules on human umbilical vein endothelial cells. Int J Immunopharmacol 1999;21:745-57.
56. Literat A, Su F, Norwicki M, Durand M, Ramanathan R, Jones CA, et al. Regulation of pro-inflammatory cytokine expression by curcumin in hyaline membrane disease (HMD). Life Sci 2001;70:253-67.
57. Banerjee M, Tripathi LM, Srivastava VM, Puri A, Shukla R. Modulation of inflammatory mediators by ibuprofen and curcumin treatment during chronic inflammation in rat. Immunopharmacol Immunotoxicol 2003;25:213-24.
58. Gaddipati JP, Sundar SV, Calemine J, Seth P, Sidhu GS, Maheshwari RK. Differential regulation of cytokines and transcription factors in liver by curcumin following hemorrhage/resuscitation. Shock 2003;19:150-6.
59. Huang CD, Tliba O, Panettieri RA Jr, Amrani Y. Bradykinin induces interleukin-6 production in human airway smooth muscle cells: Modulation by Th2 cytokines and dexamethasone. Am J Respir Cell Mol Biol 2003;28:330-8.
60. Xu YX, Pindolia KR, Janakiraman N, Chapman RA, Gautam SC. Curcumin inhibits IL1 alpha and TNF-alpha induction of AP-1 and NF-kB DNA-binding activity in bone marrow stromal cells. Hematopathol Mol Hematol 1997-98;11: 49-62.
61. Natarajan C, Bright JJ. Curcumin inhibits experimental allergic encephalomyelitis by blocking IL-12 signaling through Janus kinase-STAT pathway in T lymphocytes. J Immunol 2002;168:6506-13.
62. Pendurthi UR, Williums JT, Rao LV. Inhibition of tissue factor gene activation in cultured endothelial cells by curcumin. Suppression of activation of transcription factors Egr-1, AP-1 and NF Kappa B. Arterioscler Thromb Vase Bio 1997;17:3406-13.
63. Bierhaus A, Zhang Y, Quehenberger P, Luther T, Haase M, Muller M, et al. The dietary pigment curcumin reduces endothelial tissue factor gene expression by inhibiting binding of AP-1 to the DNA and activation of NF-kappa B. Thromb Haemost 1997;77:772-82.
64. Singh S, Aggarwal BB. Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane). J Biol Chem 1995;270:24995-5000.
65. Brennan P, O'Neill LA. Inhibition of nuclear factor kappa B by direct modification in whole cells - mechanism of action of nordihydroguaiaritic acid, curcumin and thiol modifiers. Biochem Pharmacol 1998;55:965-73.
66. Jobin C, Bradham CA, Russo MP, Juma B, Narula AS, Brenner DA, Sartor RB. Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. J Immunol 1999;163:3474-83.
67. Bremner P, Heinrich M. Natural products as targeted modulators of the nuclear factor-kappa B pathway. J Pharm Pharmacol 2002;54:453-72.
68. Sugimoto K, Hanai H, Tozawa K, Aoshi T, Uchijima M, Nagata T, et al. Curcumin prevents and ameliorates trinitrobenzene sulfonic acid-induced colitis in mice. Gastroenterology 2002;123:1912-22.
69. Bharti AC, Donato N, Singh S, Aggarwal BB. Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood 2003;10:1053-62.
70. Nanji AA, Jokelainen K, Tipoe GL, Rahemtulla A, Thomas P, Dannenberg AJ. Curcumin prevents alcohol-induced liver disease in rats by inhibiting the expression of NF-kappa B-dependent genes. Am J Physiol Gastrointest Liver Physiol 2003;284:321-7.
71. Surh YJ, Chun KS, Cha HH, Han SS, Keum YS, Park KK, et al. Molecular mechanism underlying chemopreventive activities of anti-inflammatory phytochemicals: down regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutation Res 2001;480:243-68.
72. Pan MH, Lin-Shiau SY, Lin JK. Comparative studies on the suppression of nitric oxide synthase by curcumin and its hydrogenated metabolites through down-regulation of Ikappa B kinase and NF kappa B activation in macrophages. Biochem Pharmacol 2000;60:1665-76.
73. Han SS, Keum YS, Seo HJ, Surh YJ. Curcumin suppresses activation of NF-kappaB and AP-1 induced by phorbol ester in cultured human promyelocytic leukemia cells. J Biochem Mol Biol 2002;35:337-42.
74. Chun KS, Keum YS, Han SS, Song YS, Kim SH, Surh YJ. Curcumin inhibits phorbol ester-induced expression of cyclooxygenase-2 in mouse skin through suppression of extracellular signal-regulated kinase activity and NF-kappaB activation. Carcinogenesis 2003;24:1515-24.
75. Smith RJ. Nonsteroidal anti-inflammatory agents: Regulators of the phagocytic secretion of lysosomal enzymes from guinea pig neutrophils. J Pharmacol Exp Ther 1978;207:618.
76. Weismann G. The role of lysozymes in inflammation and disease. Annu Rev Med 1967;18:97.
77. Becker EL, Henson PM. In vitro studies of immunologically induced secretion of mediators from cell and related phenomena. Adv Immunol 1973;17:93.
78. Ignaro LJ. Lysosome membrane stabilization in vivo : Effects of steroidal and non-steroidal anti-inflammatory drugs on the integrity of rat liver lysosomes. J Pharmacol Exp Ther 1972;182:179.
79. Winter CA. Non-steroidal anti-inflammatory agents. Annu Rev Pharmacol 1966;6:157.
80. Sharma OP. Antioxidant activity of curcumin and related compounds. Biochem Pharmacol 1976;25:1811-5.
81. Unnikrishnan MK, Rao MN. Inhibition of nitrite induced oxidation of hemoglobin by curcuminoids. Pharmazie 1995;50:490-2.
82. Osawa T, Sugiyama Y, Inayoshi M, Kawakishi S. Antioxidative activity of tetrahydrocurcuminoids. Biosci Biotechnol Biochem 1995;59:1609-12.
83. Iqbal M, Sharma SD, Okazaki Y, Fujisawa M, Okada S. Dietary supplementation of curcumin enhances antioxidant and phase II metabolizing enzymes in ddY male mice: Possible role in protection against chemical carcinogenesis and toxicity. Pharmacol Toxicol 2003;92:33-8.
84. Elizabeth K, Rao MNA. Effect of curcumin on hydroxyl radical generation through Fenton reaction. Int J Pharm 1989;57:173-6.
85. Elizabeth K, Rao MNA. Oxygen radical scavenging activity of curcumin. Int J Pharm 1990;58:237-40.
86. Balasubramanyam M, Koteswari AA, Kumar RS, Monickaraj SF, Maheswari JU, Mohan V. Curcumin-induced inhibition of cellular reactive oxygen species generation: Novel therapeutic implications. J Biosc 2003;28:715-21.
87. Priyadarsini KI, Maity DK, Naik GH, Kumar MS, Unnikrishnan MK, Satav JG, et al. Role of phenolic O-H and methylene hydrogen on the free radical reactions and antioxidant activity of curcumin. Free Radic Biol Med 2003;35:475-84.
88. Nakayama K, Furusu A, Xu Q, Konta T, Kitamura M. Unexpected transcriptional induction of monocyte chemoattractant protein 1 by proteasome inhibition: involvement of the c-Jun N-terminal kinase-activator protein 1 pathway. J Immunol 2001;167:1145-50.
89. Joe B, Rao UJ, Lokesh BR. Presence of an acidic glycoprotein in the serum of arthritic rats: modulation by capsaicin and curcumin. Mol Cell Biochem 1997;169:125-34.
90. Zsila F, Bikadi Z, Simonyi M. Induced circular dichroism spectra reveal binding of the anti-inflammatory curcumin to human alpha1-acid glycoprotein. Bioorg Med Chem 2004;12:3239-4.